Effects of blood transfusion on clinical and functional outcomes in patients with hip fracture

Transfusion

Volumn 43, Issue 10, 2003, Pages 1358-1365

  Halm, Ethan A ^a   Wang, Jason J ^b   Boockvar, Kenneth ^b   Penrod, Joan ^b   Silberzweig, Stacey B ^b   Magaziner, Jay ^b   Koval, Kenneth J ^b   Siu, Albert L ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DEATH; FEMALE; HEMOGLOBIN DETERMINATION; HIP FRACTURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LOCOMOTION; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; BLOOD; PATHOPHYSIOLOGY;

HEMOGLOBIN;

AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; FEMALE; HEMOGLOBINS; HIP FRACTURES; HUMANS; MALE;

EID: 0142072136     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00527.x     Document Type: Article

References (41)

1. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988;260:2700-3.
2. Welch HG, Meehan KR, Goodnough LT. Prudent strategies for elective red blood cell transfusion. Ann Intern Med 1992;116:393-402.
3. Practice guidelines for blood component therapy. A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996;84:732-47.
4. The administration of blood and blood components and the management of transfused patients. British Committee for Standards in Haematology, Blood Transfusion Task Force. Royal College of Nursing and the Royal College of Surgeons of England. Transfus Med 1999;9:227-38.
5. Calder L, Hebert PC, Carter AO, Graham ID. Review of published recommendations and guidelines for the transfusion of allogenic red blood cells and plasma. CMAJ 1997;156:S1-8.
6. Hill SR, Carless PA, Henry DA, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2002;2:CD002042.
7. Carson JL, Hill S, Carless P, Hebert P, Henry D. Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002;16:187-99.
8. Topley E, Fisher M. The illness of trauma. Br J Clin Pract 1956;1:770-6.
9. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg 1986;73:783-5.
10. Fortune JB, Feustel PJ, Saifi J, et al. Influence of hematocrit on cardiopulmonary function after acute hemorrhage. J Trauma 1987;27:243-9.
11. Johnson RG, Thurer RL, Kruskall MS, et al. Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 1992;104:307-14.
12. Weisel RD, Charlesworth DC, Mickleborough LL, et al. Limitations of blood conservation. J Thorac Cardiovasc Surg 1984;88:26-38.
13. Hebert PC, Wells G, Marshall J, et al. Transfusion requirements in critical care: a pilot study. Canadian Critical Care Trials Group. JAMA 1995;273:1439-44.
14. Bush RL, Pevec WC, Holcroft JW. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. Am J Surg 1997;174:143-8.
15. Carson JL, Terrin ML, Barton FB, et al. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998;38:522-9.
16. Lotke PA, Barth P, Garino JP, et al. Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. J Arthroplasty 1999;14:647-50.
17. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999;39:1070-7.
18. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17.
19. Hebert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 1997;155:1618-23.
20. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-6.
21. Carson JL, Duff A, Berlin JA, et al. Perioperative blood transfusion and postoperative mortality. JAMA 1998; 279:199-205.
22. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002;102:237-44.
23. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-507.
24. Magaziner J, Simonsick E, Kashner T, Hebel J, Kenzora J. Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study. J Gerontol 1990;45:M101-M107.
25. Hannan EL, Magaziner J, Wang JJ, et al. Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. JAMA 2001;285:2736-42.
26. Keeler EB, Kahn KL, Draper D, et al. Changes in sickness at admission following the introduction of the prospective payment system. JAMA 1990;264:1962-8.
27. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
28. Halm EA, Magaziner J, Hannan EL, et al. Frequency and impact of active clinical issues and new impairments on hospital discharge in patients with hip fracture. Arch Intern Med 2003;163:108-13.
29. Magaziner J, Zimmerman SI, Gruber-Baldini AL, Hebel JR, Fox KM. Proxy reporting in five areas of functional status: comparison with self-reports and observations of performance. Am J Epidemiol 1997;146:418-28.
30. Magaziner J, Simonsick EM, Kashner TM, Hebel JR. Patient-proxy response comparability on measures of patient health and functional status. J Clin Epidemiol 1988;41:1065-74.
31. Granger C. Guide for the use of the uniform data set for medical rehabilitation. Buffalo (NY): Research Foundation, State University of New York; 1987.
32. Heinemann AW, Linacre JM, Wright BD, Hamilton BB, Granger C. Relationships between impairment and physical disability as measured by the functional independence measure. Arch Phys Med Rehabil 1993;74:566-73.
33. Poses RM, Berlin JA, Noveck H, et al. How you look determines what you find: severity of illness and variation in blood transfusion for hip fracture. Am J Med 1998;105: 198-206.
34. Diehr P, Patrick DL, Spertus J, et al. Transforming self-rated health and the SF-36 scales to include death and improve interpretability. Med Care 2001;39:670-80.
35. Boockvar K, Halm EA, Litke A, et al. Hospital readmissions after hospital discharge for hip fracture: surgical and nonsurgical causes and effect on outcomes. J Am Geriatric Soc 2003;51:399-403.
36. Gruson KI, Aharonoff GB, Egol KA, Zuckerman JD, Koval KJ. The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma 2002;16:39-44.
37. Larocque BJ, Gilbert K, Brien WF. Prospective validation of a point score system for predicting blood transfusion following hip or knee replacement. Transfusion 1998; 38:932-7.
38. Larocque BJ, Gilbert K, Brien WF. A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty. Transfusion 1997;37:463-7.
39. Feagan BG, Wong CJ, Lau CY, et al. Transfusion practice in elective orthopaedic surgery. Transfus Med 2001;11:87-95.
40. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002;288:2827-35.
41. Carson JL. Should patients in intensive care units receive erythropoietin? JAMA 2002;288:2884-6.